Correlation of cord blood alkaline phosphatase level with serum bilirubin level in term neonates with jaundice: an observational study
DOI:
https://doi.org/10.18203/2349-3291.ijcp20261904Keywords:
Neonatal jaundice, Hyperbilirubinemia, Cord blood alkaline phosphatase, Serum bilirubin, PhototherapyAbstract
Background: Neonatal hyperbilirubinemia remains a significant concern in neonatal care, affecting newborn health and requiring early identification for timely intervention.
Methods: This observational study was conducted in the Department of Pediatrics at Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, from July 2024 to December 2025. A total of 145 term inborn neonates were enrolled. Cord blood samples were collected at birth for estimation of alkaline phosphatase (ALP) levels. Neonates were followed up for the first 5 d of life with daily transcutaneous bilirubin monitoring, and serum bilirubin estimation was performed when indicated. Statistical analysis included Spearman’s correlation and receiver operating characteristic (ROC) curve analysis. Sensitivity, specificity, and predictive values were calculated.
Results: Cord blood ALP levels showed a moderate positive correlation with maximum serum bilirubin levels (ρ=0.541, p=0.001). Of the 145 neonates, 33 (22.8%) required phototherapy. Roc analysis demonstrated fair predictive ability of alp for phototherapy requirement (auc=0.695). The optimal cut-off value of 117.5 u/l yielded sensitivity of 51.85%, specificity of 84.85%, positive predictive value of 91.80%, and negative predictive value of 35.0%.
Conclusions: Cord blood alp is a simple, non-invasive, and cost-effective biomarker that correlates significantly with serum bilirubin levels. It may be useful for early identification of neonates at risk of hyperbilirubinemia, enabling timely monitoring and intervention, particularly in resource-limited settings.
References
Nalbantoğlu A, Ovalı F, Nalbantoğlu B. Alkaline phosphatase as an early marker of hemolysis in newborns. Pediatr Int. 2011;53(6):936-8.
Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: types, causes, clinical examinations, preventive measures and treatments: a narrative review article. Iran J Public Health. 2016;45(5):558-68.
Ansong-Assoku B, Adnan M, Daley S, Ankola P. Neonatal jaundice. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2024.
Cloherty JP, Eichenwald EC, Hansen AR, Stark AR, editors. Cloherty and Stark's Manual of Neonatal Care. 9th ed. Philadelphia: Wolters Kluwer. 2021;342-66.
Brouillard RP. Measurement of red blood cell life-span. JAMA. 1974;230(9):1304-05.
Amato MM, Kilguss NV, Gelardi NL, Cashore WJ. Dose-effect relationship of bilirubin on striatal synaptosomes in rats. Brain Res. 1994;66(5):288-93.
Hoffman DJ, Zanelli SA, Kubin J, Mishra OP, Delivoria-Papadopoulos M. The in vivo effect of bilirubin on the N-methyl-D-aspartate receptor/ion channel complex in the brains of newborn piglets. Pediatr Res. 1996;40(6):804-8.
Ambalavanan N, Carlo WA. Jaundice and hyperbilirubinemia in the newborn. In: Kliegman RM, St Geme JW III, Blum NJ, Shah SS, Tasker RC, Wilson KM, editors. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia: Elsevier. 2023;871-8.
Knudsen A. Prediction of the development of neonatal jaundice by increased umbilical cord blood bilirubin. Acta Paediatr. 1989;78(2):217-21.
Taksande A, Vilhekar K, Jain M, Zade P, Atkari S, Verkey S. Prediction of the development of neonatal hyperbilirubinemia by increased umbilical cord blood bilirubin. Indian J Med Sci. 2005;59(1):5-9
Sahu S. Cord blood albumin as a predictor of neonatal jaundice. J Obstet Gynaecol India. 2020;81(1):1217-25.
El-Gendy F, Hassane F, Khattab A, El-Lahony D, Ashour N. Predictive ability of first-day serum bilirubin and haptoglobin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Menoufia Med J. 2013;26(2):127-31.
Satrya R, Effendi SH, Gumida DA. Correlation between cord blood bilirubin level and incidence of hyperbilirubinemia in term newborns. Pediatr Int. 2009;49(6):349-54.
Al Assal HM, Hablas HR, Afia AAE, Khedr MAA. Utility of cord blood alkaline phosphatase enzyme as a predictor of significant neonatal jaundice in well term infants. Egypt J Hosp Med. 2019;74(5):1047-52.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316.
Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2008;121(1):e170-9.
Downloads
Published
How to Cite
Issue
Section
